Compare Enzyme (MLN) vs THORChain (RUNE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs THORChain — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while THORChain trades at Rp7,435 (market cap Rp2,5T, Rp59,47M 24h volume). The key difference: THORChain is far larger — about 18638.6× Enzyme's market cap, and THORChain's supply is capped (338,2M / 354,2M RUNE (96%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and THORChain for 47 Days on average.
| MLN | RUNE | |
|---|---|---|
Market Cap | Rp134,13M | Rp2,5T |
Volume (24h) | Rp104,56M | Rp59,47M |
Circulating Supply | 3,3M MLN | 338,2M / 354,2M RUNE (96%) |
Typical Hold Time | 29 Days | 47 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
THORChain (RUNE) is trading at Rp7,625 with a market cap of Rp2.57 trillion, showing neutral technical signals overall. The asset maintains 96% circulation with strong moving average support but faces resistance near Rp7,688. Recent on-chain activity shows moderate network usage with no major protocol upgrades reported in the past month.
Outlook remains cautiously neutral with opportunities in cross-chain liquidity growth, though risks include regulatory uncertainty and typical crypto volatility. The token's utility in decentralized exchange infrastructure provides fundamental support, but investors should monitor trading volume patterns and broader market sentiment.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About THORChain
THORCHain is a decentralized liquidity protocol that allows users to easily exchange cryptocurrency assets across a range of networks without losing full custody of their assets in the process. With THORChain, users can simply swap one asset for another in a permissionless setting, without needing to rely on order books to source liquidity. The native utility token of the THORChain platform is RUNE.
Read more on RUNE →
